|
TPR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.235000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.383000E-01 |
| Normal-vs-Stage2 |
7.701400E-01 |
| Normal-vs-Stage3 |
8.337500E-03 |
| Normal-vs-Stage4 |
1.350240E-01 |
| Stage1-vs-Stage2 |
8.524200E-01 |
| Stage1-vs-Stage3 |
3.144100E-03 |
| Stage1-vs-Stage4 |
1.294220E-01 |
| Stage2-vs-Stage3 |
8.871500E-02 |
| Stage2-vs-Stage4 |
3.517600E-01 |
| Stage3-vs-Stage4 |
3.227200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.489800E-01 |
| Normal-vs-AfricanAmerican |
2.368600E-01 |
| Normal-vs-Asian |
8.802600E-01 |
| Caucasian-vs-AfricanAmerican |
6.322000E-01 |
| Caucasian-vs-Asian |
6.288400E-01 |
| AfricanAmerican-vs-Asian |
5.278400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.182600E-01 |
| Normal-vs-Female |
7.112200E-01 |
| Male-vs-Female |
1.547190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.509800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.016600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.438010E-01 |
| Normal-vs-Age(81-100Yrs) |
5.114400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.586200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.137600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.782000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.832420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.304590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.899800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.223780E-02 |
| Normal-vs-Grade 2 |
9.226600E-01 |
| Normal-vs-Grade 3 |
1.964450E-02 |
| Normal-vs-Grade 4 |
5.600000E-02 |
| Grade 1-vs-Grade 2 |
3.533700E-02 |
| Grade 1-vs-Grade 3 |
2.622900E-04 |
| Grade 1-vs-Grade 4 |
1.977740E-03 |
| Grade 2-vs-Grade 3 |
1.777670E-03 |
| Grade 2-vs-Grade 4 |
2.730500E-02 |
| Grade 3-vs-Grade 4 |
9.080600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.565800E-01 |
| Normal-vs-ccB subtype |
2.738400E-02 |
| ccA subtype-vs-ccB subtype |
1.046240E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.852600E-01 |
| Normal-vs-N1 |
8.548600E-01 |
| N0-vs-N1 |
4.491200E-01 |
|
|
